SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amid intense speculation of an improved acquisition offer from Sanofi, following a rejected $16/share bid. The community is highly optimistic about upcoming Phase 3 data for AXPAXLI in wet AMD, fueling expectations for a substantial premium or strong independent commercialization, a sentiment reinforced by a recent high-profile CCO hire.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is generating significant buzz due to ongoing V4 developments, new partnerships, and its near-max token supply, igniting a heated debate among investors about an impending 'supply shock' versus concerns over governance stability and treasury health.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token is trending as the community eagerly discusses major deflationary events, including substantial token burns from unclaimed airdrops and buybacks, alongside new product updates like video generation and enhanced API support. Its low circulating supply and utility in private, uncensored AI are key talking points, fueling optimism for significant upside.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending after delivering compelling Phase 2 data for its CAR-T therapy, NXC-201, in AL Amyloidosis, showcasing exceptional response rates and a favorable safety profile, which led to an oversubscribed institutional offering. The community is actively discussing its 'best-in-class' potential, FDA designations, and promising expansion into larger autoimmune indications, positioning IMMX as a strong buyout prospect with growing institutional confidence.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the following segments: FPL and NEER. The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEra Energy is a major talking point as its strategic partnerships with tech giants like Google and Meta position it to meet the exploding power demands of AI data centers through expanded clean and nuclear energy initiatives, leading the community to discuss its significant growth potential and role within the evolving utilities sector.

TOSHI

TOSHI is actively trending as the 'Face of Base,' with the community closely observing bullish chart patterns and anticipating a significant breakout, driven by increasing volume and broader market expectations for an altcoin season.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is a hot topic following its strong earnings beat, driven by surging demand for its power generation equipment, positioning the industrial giant as a key player in the AI data center build-out. This AI infrastructure narrative has propelled the stock to new highs, sparking widespread debate among investors over its soaring valuation and the sustainability of its remarkable momentum.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending following Medicare coverage approval for its NeXT Personal MRD test in early-stage lung cancer surveillance, marking a significant de-risking event and establishing the company as a first-mover. The community is actively discussing the substantial revenue potential and anticipating further reimbursement approvals and growth in the rapidly expanding minimal residual disease sector.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending following impressive January sales results, particularly a significant surge in digital sales, which has led to multiple analyst upgrades and increased price targets. The community is actively discussing its premium valuation relative to its consistent performance as a defensive consumer staple, with many also anticipating a potential stock split.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor ($TAO) is trending as its upcoming halving event and unique tokenomics fuel comparisons to Bitcoin's scarcity, while a Grayscale ETF filing and significant institutional investments highlight growing interest in its decentralized AI infrastructure. The community is actively discussing its long-term potential as the "Bitcoin of AI" and the value of its subnet ecosystem, despite mixed sentiment regarding its current valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cognex (NASDAQ:CGNX) VP Sells $850,597.96 in Stock

Cognex Corporation (NASDAQ:CGNX - Get Free Report) VP Laura Ann Macdonald sold 14,881 shares of the stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of...

Cognex (NASDAQ:CGNX) Director Robert Willett Sells 177,052 Shares

Cognex Corporation (NASDAQ:CGNX - Get Free Report) Director Robert Willett sold 177,052 shares of the business's stock in a transaction on Thursday, February 12th. The shares were sold at an average...

Cognex Corporation (NASDAQ:CGNX) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Cognex Corporation (NASDAQ:CGNX - Get Free Report) have received an average rating of "Moderate Buy" from the sixteen ratings firms that are currently covering the firm, MarketBeat Ratings...

Top Mid Cap Stocks To Watch Now - February 12th

ProShares UltraPro Short QQQ, Icon, Fastly, Direxion Daily TSLA Bull 2X Shares, Avadel Pharmaceuticals, American Airlines Group, and Cognex are the seven Mid Cap stocks to watch today, according to...

Cognex (NASDAQ:CGNX) Price Target Raised to $67.00 at Needham & Company LLC

Needham & Company LLC increased their target price on shares of Cognex from $47.00 to $67.00 and gave the company a "buy" rating in a research report on Thursday...

Cognex (CGNX) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Cognex Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Up

CGNX beats Q4 estimates with 35% EPS growth and 10% revenues rise, lifts margins, and shares jump more than 23% in pre-market trading.

Cognex (NASDAQ:CGNX) Releases Q1 2026 Earnings Guidance

Cognex (NASDAQ:CGNX) updated its first quarter 2026 earnings guidance. The company provided EPS guidance of 0.220-0.260 for the period, compared to the consensus estimate of 0.200. The company also...

Cognex Q4 Earnings Call Highlights

Cognex (NASDAQ:CGNX) executives said the company returned to profitable growth in 2025, supported by steady logistics demand, an uptick in factory automation spending late in the year, and ongoing...

Cognex (NASDAQ:CGNX) Sets New 12-Month High on Earnings Beat

Cognex (NASDAQ:CGNX) Reaches New 52-Week High on Strong Earnings...

$CGNX Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.20 up 17.65% YoY
• Reported revenue of $252.34M up 9.86% YoY
• Cognex projects Q1 2026 revenue of $235M to $255M, a 13% year-over-year increase at midpoint. Adjusted EBITDA margin is guided to 19.0%-22.0%, and Adjusted EPS (diluted) to $0.22-$0.26.

Stocktwits

Cognex Corp.

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $0.20 up 17.65% YoY
• Reported revenue of $252.34M up 9.86% YoY
• Cognex projects Q1 2026 revenue of $235M to $255M, a 13% year-over-year increase at midpoint. Adjusted EBITDA margin is guided to 19.0%-22.0%, and Adjusted EPS (diluted) to $0.22-$0.26.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Cognex Corp. engages in the provision of machine vision products and solutions that improve efficiency and quality in a wide range of businesses across attractive industrial end markets. It operates through the following geographical segments: the United States, Europe, Greater China, and Other. The company was founded by Robert J. Shillman, William Silver, and Marilyn Matz on January 7, 1981 and is headquartered in Natick, MA.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$58.79
Prev Close	$58.67
Open	$58.65
Dividend Yield	0.90%
50-Day Moving Average	$39.06
Beta	1.47
Avg. Volume	1.59M
PE Ratio	87.15

52-Week High	$59.88
52-Week Low	$22.67
Market Capitalization	$9.83B
EPS (Annual)	$0.68
Price to Book	6.57
Revenue Per Employee	$341,235.07

CGNX
Cognex Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CGNX News

CGNXCognex Corp.